FOLFOXFOLFIRI5-FUoxaliplatinirinotecanCRCcolorectal cancer
… differential treatment responses (figure 3):First-line therapy FOLFOX: tumor progression in metastatic lesions.Second-line therapy FO…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 4,141–4,200 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
pharmacological strategies1pharmacological weight loss treatment1phenobarbitone coma1phlebotomy1photoprotection1photothermal therapy1phrenic nerve block1phrenic nerve peripheral neuromodulation1physical activity1physical agent therapy1physical interventions1physical restraints1physical therapies1physical treatments1physician-assisted suicide1physiotherapeutic scoliosis-specific exercises1pigtail catheter drainage1placebo surgery1placebo treatment1plaque radiotherapy1plastic stents1plastic surgery1plate-and-screw fixation1platelet transfusion1platelet-rich plasma1platelet-rich plasma injections1platelet-rich plasma therapy1platinum chemotherapy1platinum doublet therapy1platinum therapy1platinum-based therapy1pneumatic balloon dilatation1pneumatic enema1poly (ADP-ribose) polymerase inhibitor therapy1polyethylene glycol bowel irrigation1popliteal sciatic nerve block1positional therapy1positive inotropic support1post-progression therapy1post-protocol treatments1postdischarge therapy1posterior C2–T2 fixation1posterior circulation interventions1posterior restorations1postmastectomy radiotherapy1postnatal corticosteroid treatment1postoperative adjuvant chemoradiation therapy1postoperative analgesia1postoperative hormonal therapies1postpartum early eye movement desensitization and reprocessing therapy1postpartum haemorrhage management1postprocedural anticoagulation1postsurgical physiotherapy1potassium-excreting therapies1pre-emptive treatment1precision oncology interventions1pregnancy-adjusted antihypertensive therapy1preoperative alpha blockade1preoperative antiplatelet therapy1preoperative chemoradiotherapy1
Articles mentioning treatments
7,227 articles · page 229 of 603cancer vaccinesimmune checkpoint inhibitorsCOVID-19CellCartaOlink Reveal10x Genomics
…apies, such as immune checkpoint inhibitors, CAR-T cells, TILs, cancer vaccines, and T cell engagers/redirectors, work by inducing a robust T c…
cancer treatmentFDAInternational Council for HarmonisationFDA-recommended
…he development and quality control of cell therapy products for cancer treatment. As advanced therapies expand into clinical oncology, there is …
81.1%
radioimmunotherapieschimeric antigen receptor (CAR)-T cell therapiescancerOSU cohort3
…ntibodies (mAbs), antibody-drug conjugates (ADCs), bispecifics, radioimmunotherapies, and chimeric antigen receptor (CAR)-T cell therapies. 1 Howeve…
ASP-1929 PITHNSCCcuSCCPembrolizumabNational Institutes of HealthIRDye®700DXASP-1929NIH
…s Across Patients Show Consistent Immune Cell Changes Following ASP-1929 PIT. Uniform Manifold Approximation and Projection (UMAP) plot show…
CAR-T therapySolid tumorsPD-L1-EphA2-4-1BBPD-L1-EphA2-CD28EphA2-PD-L1-4-1BBPD-L1-EphA2EphA2-PD-L1-CD28
…findings support the clinical development of PD-L1-EphA2 tandem CAR-T therapy for treating solid tumors expressing either or both antigens, a…
249 CD3ε enhances CAR-T fitness and persistence by promoting the survival of effector memory T cells
CAR-T therapyCAR-T Cell TherapyB-cell malignanciesAAALAC-approved facilityCAR-T
…Background CAR-T therapy has demonstrated potent anti-tumor efficacy in treating a range…
CAR-T cell therapyCAR T cell therapyPancreatic Ductal Adenocarcinomapancreatic cancerMass General Brighamsolid tumorsMGH Cancer CenterAmerican-Italian Cancer FoundationCRIS Foundation Out-Back Fellowship Programmerotein+2 more
…Background CAR-T cell therapy has shown limited efficacy in solid tumors due to factors such …
CAR-T cell immunotherapiesCAR T cell immunotherapiessolid tumors
…Background CAR-T cell immunotherapies are being avidly pursued for treatment of solid tumors. However…
immune checkpoint blockadestandard treatmentsUniversity Hospital TübingenGerman Cancer Research CenterNUT carcinomaB7-H3NGS Core FacilityOmics IT and Data Management Core FacilityDKFZB7-H3-targeted
…nreported immunologically ‘hot’ NC tumors that may benefit from immune checkpoint blockade and other immunotherapies. To uncover novel actionable targets …
ACTsolid tumorshematologic cancersmetastatic melanomaRNF166
…highlighting a promising strategy for improving the efficacy of ACT.Abstract 277 Figure 1Comprehensive analysis of proteome turnove…
Trispecific NK cell engagersantibody-drug conjugatesUniversity of MinnesotacancerJackson Laboratoryhuman IL-15
…umors and evaluated against various IO therapies such as CAR T, Trispecific NK cell engagers, and antibody-drug conjugates.Results CD34 NSG-FLT3-IL15 mice e…